102 related articles for article (PubMed ID: 15050085)
1. Adherence to treatment of depression in active injection drug users: the minerva study.
Stein MD; Herman DS; Solomon DA; Anthony JL; Anderson BJ; Ramsey SE; Miller IW
J Subst Abuse Treat; 2004 Mar; 26(2):87-93. PubMed ID: 15050085
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy plus psychotherapy for treatment of depression in active injection drug users.
Stein MD; Solomon DA; Herman DS; Anthony JL; Ramsey SE; Anderson BJ; Miller IW
Arch Gen Psychiatry; 2004 Feb; 61(2):152-9. PubMed ID: 14757591
[TBL] [Abstract][Full Text] [Related]
3. Persistence of antidepressant treatment effects in a pharmacotherapy plus psychotherapy trial for active injection drug users.
Stein MD; Solomon DA; Anderson BJ; Herman DS; Anthony JL; Brown RA; Ramsey SE; Miller IW
Am J Addict; 2005; 14(4):346-57. PubMed ID: 16188715
[TBL] [Abstract][Full Text] [Related]
4. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
[TBL] [Abstract][Full Text] [Related]
5. Identifying patients at risk of complete nonresponse in the outpatient treatment of depression.
Van HL; Dekker J; Peen J; van Aalst G; Schoevers RA
Psychother Psychosom; 2008; 77(6):358-64. PubMed ID: 18701832
[TBL] [Abstract][Full Text] [Related]
6. Remission from drug dependence symptoms and drug use cessation among women drug users in puerto rico.
Warner LA; Alegría M; Canino G
Arch Gen Psychiatry; 2004 Oct; 61(10):1034-41. PubMed ID: 15466677
[TBL] [Abstract][Full Text] [Related]
7. Tailoring an HIV-prevention intervention for cocaine injectors and crack users in Porto Alegre, Brazil.
Leukefeld CG; Pechansky F; Martin SS; Surratt HL; Inciardi JA; Kessler FH; Orsi MM; Von Diemen L; Meyer Da Silva E
AIDS Care; 2005 Jun; 17 Suppl 1():S77-87. PubMed ID: 16096120
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
[TBL] [Abstract][Full Text] [Related]
9. The association between cocaine use and short-term outcomes for the treatment of heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
Williamson A; Darke S; Ross J; Teesson M
Drug Alcohol Rev; 2006 Mar; 25(2):141-8. PubMed ID: 16627303
[TBL] [Abstract][Full Text] [Related]
10. Is psychotherapy a reliable alternative to pharmacotherapy to promote the mental health of infertile women? A randomized clinical trial.
Faramarzi M; Kheirkhah F; Esmaelzadeh S; Alipour A; Hjiahmadi M; Rahnama J
Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):49-53. PubMed ID: 18848381
[TBL] [Abstract][Full Text] [Related]
11. Depression therapy with injection drug users: results of a pilot study.
Hawkins WE; Latkin C; Green DL
Am J Drug Alcohol Abuse; 2005; 31(2):243-51. PubMed ID: 15912714
[TBL] [Abstract][Full Text] [Related]
12. Clinical effectiveness of individual cognitive behavioral therapy for depressed older people in primary care: a randomized controlled trial.
Serfaty MA; Haworth D; Blanchard M; Buszewicz M; Murad S; King M
Arch Gen Psychiatry; 2009 Dec; 66(12):1332-40. PubMed ID: 19996038
[TBL] [Abstract][Full Text] [Related]
13. Brief cognitive behavioural interventions for regular amphetamine users: a step in the right direction.
Baker A; Lee NK; Claire M; Lewin TJ; Grant T; Pohlman S; Saunders JB; Kay-Lambkin F; Constable P; Jenner L; Carr VJ
Addiction; 2005 Mar; 100(3):367-78. PubMed ID: 15733250
[TBL] [Abstract][Full Text] [Related]
14. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention.
Koester S; Glanz J; Barón A
AIDS Behav; 2005 Mar; 9(1):27-39. PubMed ID: 15812611
[TBL] [Abstract][Full Text] [Related]
15. Do supervised injecting facilities attract higher-risk injection drug users?
Wood E; Tyndall MW; Li K; Lloyd-Smith E; Small W; Montaner JS; Kerr T
Am J Prev Med; 2005 Aug; 29(2):126-30. PubMed ID: 16005809
[TBL] [Abstract][Full Text] [Related]
16. Cortisol levels and depression in men and women using heroin and cocaine.
Wisniewski AB; Brown TT; John M; Cofranceso J; Golub ET; Ricketts EP; Wand G; Dobs AS
Psychoneuroendocrinology; 2006 Feb; 31(2):250-5. PubMed ID: 16157457
[TBL] [Abstract][Full Text] [Related]
17. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.
McDowell D; Nunes EV; Seracini AM; Rothenberg J; Vosburg SK; Ma GJ; Petkova E
Drug Alcohol Depend; 2005 Nov; 80(2):209-21. PubMed ID: 15913920
[TBL] [Abstract][Full Text] [Related]
18. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users.
Day C; Conroy E; Lowe J; Page J; Dolan K
Aust J Rural Health; 2006 Jun; 14(3):120-5. PubMed ID: 16706881
[TBL] [Abstract][Full Text] [Related]
19. The impact of borderline personality disorder on 12-month outcomes for the treatment of heroin dependence.
Darke S; Ross J; Williamson A; Teesson M
Addiction; 2005 Aug; 100(8):1121-30. PubMed ID: 16042642
[TBL] [Abstract][Full Text] [Related]
20. Interventions for adolescent depression in primary care.
Stein RE; Zitner LE; Jensen PS
Pediatrics; 2006 Aug; 118(2):669-82. PubMed ID: 16882822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
